Hazard
270 recalls in our database tag this hazard, drawn from FDA, USDA FSIS, CPSC, and NHTSA source notices.
Of the 270 dissolution failure recalls we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 10 (4%) are Severe.
Hazard tags are short, machine-readable labels we attach to every recall to make cross-cutting queries possible — “all dissolution failure recalls regardless of agency”, “all listeria recalls in California”, “all airbag recalls in 2025”. The tags are extracted from each recall’s source text during the LLM rewrite step and validated against a fixed schema.
A recall can carry multiple tags — a Listeria recall might also be tagged ready-to-eat and undeclared-allergen. Use the full-text search if you want to combine hazard tags with brand or category filters.
Perrigo Holland Inc is recalling CareOne Nicotine Polacrilex Lozenges because they failed dissolution tests and contained broken lozenges.
Wockhardt USA is recalling specific lots of Metoprolol Succinate Extended-Release Tablets because they failed dissolution testing. The recall covers 11,661 bottles distributed nationwide.
McKesson Packaging Services is recalling Aspirin DR Enteric Coated Tablets because they failed to meet dissolution specifications at the 12-month time interval.
Sandoz Inc. is recalling Orphenadrine Citrate Extended Release Tablets because they failed dissolution specifications during stability testing.
Forest Pharmaceuticals is recalling Bystolic (nebivolol) 20 mg tablets because they failed stage III dissolution testing. The recall affects 92,544 bottles distributed nationwide.
Caraco Pharmaceutical Laboratories is recalling specific lots of Venlafaxine Hydrochloride Extended-Release Tablets, 150 mg, because stability results showed the product did not meet drug dissolution specifications.
West-Ward Pharmaceutical Corp. is recalling Isoniazid Tablets, USP, 300 mg because stability lots failed to meet dissolution specifications.
Dr. Reddy's is recalling specific lots of Metoprolol Succinate Extended Release Tablets because they failed dissolution testing at 18 months.
Wockhardt USA LLC is recalling 8,712 bottles of Metoprolol Succinate Extended-Release Tablets, 100 mg, because they failed dissolution testing.
Forest Pharmaceuticals is voluntarily recalling one lot of Bystolic (nebivolol hydrochloride) tablets because dissolution test results failed to meet specifications.
Wockhardt USA is recalling specific lots of Metoprolol Succinate Extended-Release Tablets because they failed dissolution testing at the nine-month time point.
Caraco Pharmaceutical Laboratories is recalling 91,777 bottles of Venlafaxine Hydrochloride Extended-Release Tablets, 37.5 mg, because stability results showed the product did not meet drug release dissolution specifications.
Caraco Pharmaceutical Laboratories is recalling 160,105 bottles of Venlafaxine Hydrochloride Extended-Release Tablets, 150 mg, because stability results showed the product did not meet drug release dissolution specifications.
McKesson Packaging Services is recalling 1,557 boxes of Venlafaxine Hydrochloride Extended Release Capsules, 150 mg, due to out-of-specification dissolution results.
Actavis Elizabeth LLC is recalling 5,148 bottles of Alprazolam Extended-Release Tablets, 3 mg, because the product failed to meet dissolution specifications.
Forest Pharmaceuticals is recalling 3,950 packs of Namenda XR titration packs because they failed stability dissolution testing.
Corepharma LLC is recalling Pyridostigmine Bromide Tablets USP 60 mg because they failed a dissolution test at the 30-month stability time point.
Dr. Reddy's is recalling specific lots of Metoprolol Succinate Extended-Release Tablets because they failed dissolution specifications and a 12-month stability interval.
Pfizer is recalling specific bottles of Glucotrol XL tablets because they failed to meet dissolution specifications at the 8-hour stability timepoint.
Greenstone LLC is recalling 22,529 bottles of Glipizide XL 5 mg tablets because a bulk lot failed a dissolution specification test.
Forest Pharmaceuticals is recalling 156 bottles of Namenda XR 7 mg capsules because they failed stability dissolution testing. The affected product was distributed nationwide and in Puerto Rico.
Forest Pharmaceuticals is recalling Namenda XR sample packs because they failed stability dissolution testing. The affected lots were distributed nationwide and in Puerto Rico.
Wockhardt USA is recalling 1,129 bottles of Pantaprazole Sodium 40 mg tablets because they failed dissolution specifications.
Actavis Inc is recalling Bupropion Hydrochloride Extended-Release Tablets because they failed stability testing for dissolution specifications at 18 months.
Amedra Pharmaceuticals is recalling 10,992 bottles of Dexedrine Spansules 15mg due to failed dissolution specifications at the 32-month stability level.